Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2016 2
2017 2
2018 1
2019 1
2020 2
2021 4
2022 8
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
Ahenkorah S, Cassells I, Deroose CM, Cardinaels T, Burgoyne AR, Bormans G, Ooms M, Cleeren F. Ahenkorah S, et al. Among authors: ooms m. Pharmaceutics. 2021 Apr 21;13(5):599. doi: 10.3390/pharmaceutics13050599. Pharmaceutics. 2021. PMID: 33919391 Free PMC article. Review.
First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B.
Wakabayashi Y, Stenkrona P, Arakawa R, Yan X, Van Buskirk MG, Jenkins MD, Santamaria JAM, Maresca KP, Takano A, Liow JS, Chappie TA, Varrone A, Nag S, Zhang L, Hughes ZA, Schmidt CJ, Doran SD, Mannes A, Zanotti-Fregonara P, Ooms M, Morse CL, Zoghbi SS, Halldin C, Pike VW, Innis RB. Wakabayashi Y, et al. Among authors: ooms m. J Nucl Med. 2022 Dec;63(12):1919-1924. doi: 10.2967/jnumed.122.263838. Epub 2022 Jun 30. J Nucl Med. 2022. PMID: 35772961 Free PMC article.
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE.
Vermeulen K, Van de Voorde M, Segers C, Coolkens A, Rodriguez Pérez S, Daems N, Duchemin C, Crabbé M, Opsomer T, Saldarriaga Vargas C, Heinke R, Lambert L, Bernerd C, Burgoyne AR, Cocolios TE, Stora T, Ooms M. Vermeulen K, et al. Among authors: ooms m. Pharmaceutics. 2022 Nov 23;14(12):2566. doi: 10.3390/pharmaceutics14122566. Pharmaceutics. 2022. PMID: 36559060 Free PMC article.
Retention of [(18)F]fluoride on reversed phase HPLC columns.
Ory D, Van den Brande J, de Groot T, Serdons K, Bex M, Declercq L, Cleeren F, Ooms M, Van Laere K, Verbruggen A, Bormans G. Ory D, et al. Among authors: ooms m. J Pharm Biomed Anal. 2015;111:209-14. doi: 10.1016/j.jpba.2015.04.009. Epub 2015 Apr 9. J Pharm Biomed Anal. 2015. PMID: 25898315
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy.
Van de Voorde M, Duchemin C, Heinke R, Lambert L, Chevallay E, Schneider T, Van Stenis M, Cocolios TE, Cardinaels T, Ponsard B, Ooms M, Stora T, Burgoyne AR. Van de Voorde M, et al. Among authors: ooms m. Front Med (Lausanne). 2021 Jul 19;8:675221. doi: 10.3389/fmed.2021.675221. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34350194 Free PMC article.
24 results